Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III Safety and Efficacy Study of Dexmedetomidine in Mechanically Ventilated Preterm Neonates and Pediatric ICU Patients
2017-000408-71Phase 2
- Sponsor
- Hospira, Inc.
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexmedetomidine in sedation, sponsored by Hospira, Inc. Primary endpoint: Use of rescue sedative/analgesic medication.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on 2017-000408-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000408-71.